Transparency Market Research observes that the competitive landscape in the global plasma fractionation market is decently fragmented with several players investing in research and development. However as competition intensifies, players are expected to design organic and in-organic growth strategies to improve their product offerings and expand their geographical reach. In the coming years, commercialization of affordable proteins derived from plasma fractionation will be the primary focus on the vendors in the global plasma fractionation market. The key players in the global market for plasma fractionation market are CSL Limited, Shire plc, Sanquin, GRIFOLS, and Baxter International Inc.
The global plasma fractionation market was worth US$18,420.00 nn in 2017 and is estimated to rise to US$33,763.10 mn by 2026, as the market promises to exhibit a CAGR of 7.1% between 2018 and 2026. In terms of geography, North America plasma fractionation market is expected to dominate as the regional market is open to technological advancements. Thus, improving infrastructure of ambulatory services, private duty nursing, and rise of chronic degenerative diseases are expected to propel the regional market in the coming years. Out of the many products, immunoglobulin is projected to lead the global market for plasma fractionation as it is an irreplaceable element of several treatments for autoimmune and acute inflammatory conditions.
Rise in Indications to Primarily Drive Global Plasma Fractionation Market
Growing awareness of diseases due to proliferation of media and growing number of diagnostic centers have raised the stakes for plasma fractionation, which is the first step toward large-scale protein purification. A consistent rise in indications and growing usage of plasma-derived proteins for various therapeutics has become the primary growth driver for global plasma fractionation market. In the coming years, the rise in investment to design therapeutics for rare diseases is also projected to bode well for the global plasma fractionation market. Increasing efforts to make procedures for fractioning proteins from plasma affordable are also likely to work in favor of the market during the forecast years.
Currently, plasma fractionation industry is involved in research and development of therapies such as Ceruloplasmin, IgA, and Plasmin. These therapies are expected to offer a multitude of benefits to patients. For instance, vendors in the market are focusing on increasing the capacities of plasma fractionation and purification of a wide range of proteins, which is expected to bring in phenomenal technological advancements along with cost-effectiveness.
Affordability and Safety of Recombinant Protein Therapies Could Dampen Market Revenue
On the flip side, the global plasma fractionation market faces a few challenges as well. For instance, several pharmaceutical giants are developing recombinant proteins, which is anticipated to eat into the sales of plasma derived proteins. The safety of recombinant protein therapy has become its obvious reason for success over proteins derived from plasma fractionation. A clear example of this can be seen in the recombinant products that are used for treating hemophilia. These products are not only safe but also affordable and thus can be used across a wide spectrum of patients.
This review is based on Transparency Market Research’s report, titled “Plasma Fractionation Market (Product Type - Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors; Applications - Neurology, Immunology, Hematology, Critical Care, Pulmonology; End use - Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026”.
Global Plasma Fractionation Market Analysis and Forecast, by Product
- Intravenous Immunoglobulin
- Subcutaneous Immunoglobulin
- Coagulation Factor Concentrates
- Factor VIII
- Factor IX
- Factor XIII
- Prothrombin Complex Concentrates
- Von Willebrand Factor (VWF)
- Fibrinogen Concentrates
- Protease Inhibitors
- Other Plasma Products
Global Plasma Fractionation Market Analysis and Forecast, by Application
- Critical Care
- Other Applications
Global Plasma Fractionation Market Analysis and Forecast, by End Users
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Global Plasma Fractionation Market Analysis and Forecast, by Geography
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC